|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
30.100 -0.700 (-2.273%) | 2021/12 - Final RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 2,579,774 | 3,222,413 | 2,950,105 | 2,580,226 |
| Net Cash from / (used in) Investing Activities | -- | (4,706,229) | (171,962) | (5,244,915) | (10,504,102) |
| Net Cash from / (used in) Financing Activities | -- | 1,467,129 | (1,935,979) | 3,137,535 | 9,908,627 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (659,326) | 1,114,472 | 842,725 | 1,984,751 |
| Cash & Cash Equivalents at beginning of period | -- | 8,284,371 | 7,175,005 | 6,350,319 | 4,538,037 |
| Effect of Foreign Exchange Rate Changes | -- | (300,164) | (5,106) | (18,039) | (172,469) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 7,324,881 | 8,284,371 | 7,175,005 | 6,350,319 |
| Remarks: | Real time quote last updated: 24/06/2022 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,735,270 |
| %Change | 29.280% |
| EPS / (LPS) | RMB 1.850 |
| NBV Per Share (¥) | RMB 15.270 |